Sharon Smith

A phase 3 trial evaluates the efficacy and safety of nilotinib with pegylated interferon alfa-2a in patients with newly diagnosed chronic-phase chronic myeloid leukemia. Medscape Medical News source https://www.medscape.com/viewarticle/combo-therapy-boosts-early-cml-response-not-long-term-2026a1000f6z?src=rss

U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F.... Reuters Health Information source https://www.medscape.com/s/viewarticle/exclusive-kennedys-health-officials-explored-us-ban-some-2026a1000exu?src=rss

The UK seized over two million illicit medicine doses in March — more than any other country in a 90-nation INTERPOL crackdown that netted 6.42 million doses globally. Medscape News UK source https://www.medscape.com/viewarticle/uk-tops-global-seizures-illicit-medicine-crackdown-2026a1000eyx?src=rss

Ambient AI systems may reduce documentation demands and allow physicians to spend more time interacting directly with patients during their visits. Medscape News Europe source https://www.medscape.com/viewarticle/could-ai-copilots-reduce-clinician-documentation-time-2026a1000ets?src=rss

Nicotinamide supplementation confers a statistically significant risk reduction for melanoma in patients with a prior nonmelanoma skin cancer, a cohort study finds. Medscape Medical News source https://www.medscape.com/viewarticle/nicotinamide-linked-lower-melanoma-risk-patients-previous-2026a1000etj?src=rss

Migraine is linked to a 30% lower risk for dementia and a 42% lower risk for Alzheimer’s disease than not having migraine, a new cohort study shows. Medscape Medical News source https://www.medscape.com/viewarticle/migraine-tied-lower-dementia-alzheimers-risk-2026a1000et8?src=rss